ArticleMalaria journal2025
Impact of combined vector control interventions on Anopheles gambiae sensu lato resistance dynamics in a high pyrethroid resistance settings in Southwestern Burkina Faso.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Agricultural practices drive multifactorial pyrethroid resistance in Anopheles coluzzii populations from southern Benin.Tropical medicine and health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe widespread emergence of insecticide resistance in malaria vectors, particularly Anopheles gambiae, poses a significant challenge to malaria control in sub-Saharan Africa. In Burkina Faso, where pyrethroid resistance is driven by both target-site mutations and enhanced metabolic detoxification, the efficacy of key vector control tools such as insecticide-treated nets (ITNs) and indoor residual spraying (IRS) has declined. In response, alternative non-pyrethroid interventions are being implemented. This study investigated the impact of non-pyrethroid IRS and piperonyl butoxide (PBO)-synergist pyrethroid ITNs on insecticide resistance dynamics in An. gambiae populations in Kampti and Gaoua, southwestern Burkina Faso.
methodsAnopheles gambiae larvae were collected annually from 2021 to 2023, between the months of August and September. Adult susceptibility to pyrethroids insecticides was assessed using WHO tube assays. Molecular assays were used for species identification within the An. gambiae complex and detection of the kdr mutations. Expression of metabolic resistance genes was quantified using qPCR. KD60 and mortality rates were compared across intervention: during IRS use (2021), after its replacement with PBO-ITNs (2022), and after 2 years of PBO-ITN implementation (2023).
resultsThree Anopheles species were identified, 397 An. gambiae sensu stricto (66.17%; 95%CI 62.30-69.80) 149 Anopheles arabiensis (; 24.83%; 95%CI 21.50-28.40) and 54; Anopheles coluzzii (9%; 95CI 6.96-11.60). with An. gambiae being predominant. The L1014F mutation was highly prevalent, while L1014S was undetected. Following the withdrawal of IRS and the introduction of PBO-ITNs in 2022, pyrethroid resistance intensified in Kampti, with reduced mortality to permethrin and alphacypermethrin. PBO pre-exposure partially restored deltamethrin susceptibility in Kampti and fully restored it in Gaoua. By 2023, resistance remained high, particularly to alphacypermethrin, and PBO's synergistic effect diminished. Overexpression of CYP6M2 and CYP6Z1 was consistently observed, suggesting enhanced metabolic resistance.
conclusionThe findings indicated that while PBO-ITNs initially improved vector susceptibility to pyrethroids, their efficacy declined over time. This study underscores the dynamic nature of insecticide resistance and highlights the need for sustained resistance monitoring and diversified vector control strategies in high-resistance settings like southwestern Burkina Faso.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.